Overview

Safety of SPD417 Combined With Other Psychotropic Medications in the Treatment of Bipolar I Disorder

Status:
Completed
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of SPD417 when given with other psychotropic medications to treat bipolar I disorder.
Phase:
Phase 3
Details
Lead Sponsor:
Validus Pharmaceuticals
Treatments:
Carbamazepine
Psychotropic Drugs